Hepalink Pharma kicks off $585m Hong Kong listing

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Hepalink Pharma kicks off $585m Hong Kong listing

Jonathan Breen
June 24, 2020 10:45 AM
Pharma_drugs_adobe_575x375.jpg

Shenzhen Hepalink Pharmaceutical Group launched its Hong Kong IPO this week, targeting proceeds of HK$4.53bn ($585m).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC SecuritiesEquity IPOsHealth and BiotechEquityChina Merchants Bank CoChinaHong Kong SARICBCAsiaGreater ChinaHaitong SecuritiesMorgan StanleyNortheast AsiaShanghai Pudong Development BankAsia PacificEmerging MarketsSRIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article